Ghimas Fisiograft Nano HA Reinforced - Bone Regeneration Material - 2x1ml
Prix
$135.00
inc. T.V.A.
Impossible de charger la disponibilité de la réception
Vous pouvez nous contacter pour vos commandes et questions. +90543 456 2614
Toutes vos commandes sont envoyées par fret aérien rapide avec UPS EXPRESS Shipping
Vos commandes seront préparées et expédiées sous 3 jours ouvrés.
Le dédouanement dans votre pays n'est pas à la charge du vendeur.
Fisiograft Nano H.A.
- Consists of granules placed in a syringe, enabling direct application to the bone defect.
- Granules are produced from a nanohydroxyapatite and polylactic-polylglycolic copolymer composite material.
- These components have been used for years in space maintainers for guided bone tissue regeneration.
- It permeates with blood from host tissue and, thanks to the presence of hydroxyapatite, becomes a support for ossification of new bone tissue at the application site.
FISIOGRAFT nano-H.A. reinforced
- Consists of granules placed in a syringe, enabling direct application to the bone defect.
- Granules are produced from a nanohydroxyapatite-dextran composite material with a polylactic-polylglycolic copolymer mixture used as carrier.
- Components have been used for years in space maintainers for guided bone tissue regeneration.
- It permeates with blood from bone and, thanks to the presence of nanometric hydroxyapatite, becomes a nucleus for ossification of new bone tissue at the application site.
OSSEOINTEGRATION IN 6–9 MONTHS
- Composition: Hydroxyapatite 47% (470 mg), PLGA 5% (50 mg), Dextran 18% (180 mg), PEG 30% (300 mg)
- Granule size: 70><100 nm
- Packaging: 2x1ml syringe
HYDROXYAPATITE
- Patented manufacturing process
- Characteristics that mimic the structural, dimensional and biofunctional properties of natural hydroxyapatite found in dentin, cementum and bone
- Non-resorbable structure that provides osseointegration
- Less inflammatory than normal hydroxyapatite
- Leads to increased production of bone alkaline phosphatase and osteocalcin, indicating increased bone production
READY TO USE
- Histomorphometric analysis shows 42% newly formed bone, 21% nano-hydroxyapatite, and 37% medullary spaces.
- This result was obtained with FISIOGRAFT NANO HA REINFORCED just four months after surgery.
- This value is comparable to results obtained with autologous bone or other space maintainers after 6–8 months as stated in the literature (2, 3).
ADVANTAGES OF FISIOGRAFT NANO HA REINFORCED
- RESORPTION + OSSEOINTEGRATION
- PLGA degradation within 3–6 months to make room for newly formed bone
- Hydroxyapatite integrates with the mineralized structure of bone
- NO RISK: BSE – HIV – HBV – SARS
- High biocompatibility
- Easy application
